Skip to content

Q-switched nanosecond laser and picosecond laser in the treatment of nevus of Ota: A Prospective, Randomized, Self-control Study.

Q-switched nanosecond laser and picosecond laser in the treatment of nevus of Ota: A Prospective, Randomized, Self-control Study.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022690
Enrollment
Unknown
Registered
2019-04-22
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nevus of Ota

Interventions

1:Q-switched nanosecond laser
2:picosecond laser

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients that were diagnosed as nevus of Ota, aged > 1 year, male or female; (2) The patient has never received other treatments for nevus of Ota; (3) The lesion of nevus of Ota is larger than 3 cm 2; (4)After fully understanding the treatment plan and risk, the parents signed informed consent, willing to accept the self-control study with long-term trials, and with long-term follow-up.

Exclusion criteria

Exclusion criteria: (1) Patients with acute diseases; (2) Pregnant women or women who have plans for pregnancy; (3) Allergy to topical anesthetics; (4) The lesions were ulcer or eczema; (5) Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Clinical efficiency;

Secondary

MeasureTime frame
clearing rate of hyperpigmentation;

Countries

China

Contacts

Public ContactMa Gang

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

docmagang@126.com+86 13391063602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026